Cargando…
Efficacy and safety of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis
Mycophenolate mofetil (MMF) is an immunosuppressive agent (IS) which is widely prescribed in neuromyelitis optica spectrum disorder (NMOSD) patients. We aim to assess the efficacy and safety of MMF in controlling relapse and disease severity. Eligible studies obtained from the EMBASE and Ovid MEDLIN...
Autores principales: | Songwisit, Sakdipat, Kosiyakul, Punchika, Jitprapaikulsan, Jiraporn, Prayoonwiwat, Naraporn, Ungprasert, Patompong, Siritho, Sasitorn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541495/ https://www.ncbi.nlm.nih.gov/pubmed/33028926 http://dx.doi.org/10.1038/s41598-020-73882-8 |
Ejemplares similares
-
Effect of plasma exchange in neuromyelitis optica spectrum disorder: A systematic review and meta‐analysis
por: Kosiyakul, Punchika, et al.
Publicado: (2020) -
Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports
por: Tisavipat, Nanthaya, et al.
Publicado: (2022) -
Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis
por: Srikajon, Jindapa, et al.
Publicado: (2018) -
Safety and efficacy of mycophenolate mofetil in treating neuromyelitis optica spectrum disorders: a protocol for systematic review and meta-analysis
por: Han, Mengyu, et al.
Publicado: (2020) -
Dose effects of mycophenolate mofetil in Chinese patients with neuromyelitis optica spectrum disorders: a case series study
por: Jiao, Yujuan, et al.
Publicado: (2018)